Happy Tuesday! Unlike a certain president of the United States, we’re going to send this newsletter on time and not inexplicably make you wait an extra two hours for it.
Quick Hits: Today’s Top Stories
Novavax announced yesterday its nanoparticle, protein-based COVID-19 vaccine was 100 percent effective at preventing moderate and severe disease in Phase III trials, and 90 percent effective overall (including 93 percent effective against “predominantly circulating Variants of Concern and Variants of Interest”). If the vaccine receives regulatory approval, the Maryland-based company said it remains on track to manufacture 100 million doses per month by the end of Q3 2021 and 150 million doses per month by the end of Q4 2021.
President Joe Biden and Turkish President Recep Erdoğan met in Brussels yesterday during the annual NATO leaders summit, with Biden characterizing their discussion as “positive and productive.” It was the pair’s first face-to-face meeting since the Biden administration formally recognized the Armenian Genocide and the Trump administration sanctioned Turkey for purchasing a Russian missile system.
The Senate voted 53-44 yesterday to confirm Judge Ketanji Brown Jackson to the U.S. Court of Appeals for the D.C. Circuit, filling the vacancy created by Merrick Garland’s attorney general nomination. Jackson is widely believed to be on President Biden’s Supreme Court shortlist.
British Prime Minister Boris Johnson announced a four-week delay to the end of the United Kingdom’s coronavirus lockdown, pushing the country’s full reopening back from June 21 to July 19. “We are so concerned by the Delta variant,” Johnson said Monday. “We can simply keep going with all of step 4 on June 21 even though there is a real possibility that the virus will outrun the vaccines and that thousands more deaths would ensue that could otherwise have been avoided. Or else we can give our NHS a few more crucial weeks to get those remaining jabs into the arms of those who need them.”
A pair of studies published in the U.K. and Scotland Monday found that existing vaccines provide significant protection against the Delta COVID-19 variant. Two doses of Pfizer/BioNTech’s vaccine, for example, reduced the risk of hospitalization with the Delta variant by 96 percent in a Public Health England report. A Scottish analysis found two doses of Pfizer/BioNTech’s vaccine to reduce the risk of infection with the Delta variant by 79 percent.
Reality Winner—the former National Security Agency contractor sentenced in 2018 to more than five years in prison for leaking information about Russia’s attempts to influence the 2016 election—was released on Monday, according to her lawyer.
The United States confirmed 11,605 new cases of COVID-19 yesterday per the Johns Hopkins University COVID-19 Dashboard. An additional 160 deaths were attributed to the virus on Monday, bringing the pandemic’s American death toll to 599,928. According to the Centers for Disease Control, 13,944 Americans are currently hospitalized with COVID-19. Meanwhile, 1,323,282 COVID-19 vaccine doses were administered yesterday, with 174,234,573 Americans having now received at least one dose. (There was a glitch with the Johns Hopkins testing data yesterday.)

The Department of Justice News, Explained
As we noted in the Quick Hits section of yesterday’s TMD, the New York Times reported late last week that the Department of Justice subpoenaed Apple in 2017 and 2018 for data associated with the accounts of Adam Schiff and Eric Swalwell, two Democratic members of the House Intelligence Committee and vocal critics of former President Donald Trump, as well as some staffers and family members.
Want to see more of The Dispatch in Google search?
Add Us as a Preferred Source



